메뉴 건너뛰기
Urologic Oncology: Seminars and Original Investigations
Volumn 27, Issue 6, 2009, Pages 583-584
Limitations and use of PSA derivatives in the screening and risk stratification of prostate cancer
Author keywords

[No Author keywords available]
Indexed keywords

PROSTATE SPECIFIC ANTIGEN;
EID: 70350511394     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2009.06.011     Document Type: Editorial
Times cited : (1)
References (7)
  • 1
    • 63249118690 scopus 로고    scopus 로고
    • Screening and prostate-cancer mortality in a randomized European study
    • Schroder F.H., Hugosson J., Roobol M.J., et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360 (2009) 1320-1328
    • (2009) N Engl J Med , vol.360 , pp. 1320-1328
    • Schroder, F.H.1    Hugosson, J.2    Roobol, M.J.3
  • 2
    • 63249122661 scopus 로고    scopus 로고
    • Mortality results from a randomized prostate-cancer screening trial
    • Andriole G.L., Grubb III R.L., Buys S.S., et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360 (2009) 1310-1319
    • (2009) N Engl J Med , vol.360 , pp. 1310-1319
    • Andriole, G.L.1    Grubb III, R.L.2    Buys, S.S.3
  • 3
    • 2442715038 scopus 로고    scopus 로고
    • Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter
    • Thompson I.M., Pauler D.K., Goodman P.J., et al. Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter. N Engl J Med 350 (2004) 2239-2246
    • (2004) N Engl J Med , vol.350 , pp. 2239-2246
    • Thompson, I.M.1    Pauler, D.K.2    Goodman, P.J.3
  • 4
    • 33750582502 scopus 로고    scopus 로고
    • Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability
    • Carter H.B., Ferrucci L., Kettermann A., et al. Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability. J Natl Cancer Inst 98 (2006) 1521-1527
    • (2006) J Natl Cancer Inst , vol.98 , pp. 1521-1527
    • Carter, H.B.1    Ferrucci, L.2    Kettermann, A.3
  • 5
    • 3042727071 scopus 로고    scopus 로고
    • Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy
    • D'Amico A.V., Chen M.H., Roehl K.A., et al. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med 351 (2004) 125-135
    • (2004) N Engl J Med , vol.351 , pp. 125-135
    • D'Amico, A.V.1    Chen, M.H.2    Roehl, K.A.3
  • 6
    • 35748951891 scopus 로고    scopus 로고
    • Expectant management of prostate cancer with curative intent: An update of the Johns Hopkins experience
    • Discussion 2364-5
    • Carter H.B., Kettermann A., Warlick C., et al. Expectant management of prostate cancer with curative intent: An update of the Johns Hopkins experience. J Urol 178 (2007) 2359-2364 Discussion 2364-5
    • (2007) J Urol , vol.178 , pp. 2359-2364
    • Carter, H.B.1    Kettermann, A.2    Warlick, C.3
  • 7
    • 2442600143 scopus 로고    scopus 로고
    • Serum pro-prostate specific antigen preferentially detects aggressive prostate cancers in men with 2 to 4 ng/ml prostate specific antigen
    • Catalona W.J., Bartsch G., Rittenhouse H.G., et al. Serum pro-prostate specific antigen preferentially detects aggressive prostate cancers in men with 2 to 4 ng/ml prostate specific antigen. J Urol 171 (2004) 2239-2244
    • (2004) J Urol , vol.171 , pp. 2239-2244
    • Catalona, W.J.1    Bartsch, G.2    Rittenhouse, H.G.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.